Fig. 2From: Mathematical pharmacodynamic modeling for antimicrobial assessment of ceftazidime/colistin versus gentamicin/meropenem combinations against carbapenem-resistant Pseudomonas aeruginosa biofilmThe detected bioburden level post-treatment of bacterial biofilms (CRPA-45 and CRPA-47) with variable concentrations of ceftazidime/colistin (a and b) and gentamicin/meropenem combinations (c and d)Back to article page